The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,488,757 in first-year total cost, median $662,278.
Most frequent study sections
- AIDS Discovery and Development of Therapeutics Study Section[ADDT]3
- Special Emphasis Panel[ZRG1 AARR-J (56)]1
- Special Emphasis Panel[ZRG1-AARR-P(02)M]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- METHODIST HOSPITAL RESEARCH INSTITUTE1
- NAVIGEN, INC.1
- OAK CREST INSTITUTE OF SCIENCE1
- RESEARCH TRIANGLE INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis1R01AI120749-01A1 | GRATTONI, ALESSANDRO | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $819,857 | ADDT |
| 2016 | Depot formulation of a D-peptide HIV entry inhibitor1R56AI127092-01 | MUELLER, ALAN L | NAVIGEN, INC., UT | $524,908 | ZRG1 |
| 2015 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention1R01AI120748-01 | BAUM, MARC MICHAEL | OAK CREST INSTITUTE OF SCIENCE, CA | $867,958 | ADDT |
| 2015 | End-user research to optimize adherence to injectable HIV prevention approaches1R01MH105262-01A1 | MONTGOMERY, ELIZABETH TRASK | RESEARCH TRIANGLE INSTITUTE, NC | $613,756 | ADDT |
| 2014 | Towards complete sustained release nanoformulations of NRTI based regimens1R01AI114405-01 | FREEL MEYERS, CAREN L.OWEN, ANDREW | JOHNS HOPKINS UNIVERSITY, MD | $662,278 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.